Impact Advisory Board
The Impact Advisory Board (IAB) provides thought leadership and research expertise to guide Family Reach as we measure our impact on the financial burden of cancer. In order to provide comprehensive and meaningful services for patients and caregivers, Family Reach conducts ongoing measurement and evaluation of our services, including stakeholder surveys, literature reviews, intervention analyses, and focus groups. The Impact Advisory Board advises Family Reach on the strategy, design and delivery of these initiatives to ensure success in our data collection, analysis, and program improvements. The IAB also offers, contributes and reacts to new ideas that further enhance our mission of removing financial barriers to treatment in an equitable and accessible manner.
Peter C. Adamson, MD
Children’s Hospital of Philadelphia
Children’s Oncology Group
Blue Ribbon Panel, National Cancer Moonshot
Kira Bona, MD, MPH
Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
Joe Chabot, MS
Dana-Farber/Boston Children’s Cancer & Blood Disorders Center
Lorraine T. Dean, ScD
Johns Hopkins Bloomberg School of Public Health
Elizabeth Franklin, PhD, MSW
Sanofi
David Hong, MD
MD Anderson Cancer Center
Ryan Nipp, MD
Harvard Medical School
Massachusetts General Hospital
Scott Ramsey, MD
Fred Hutchinson Cancer Research Center
University of Washington Medical Center
Veena Shankaran, MD
Fred Hutchinson Cancer Research Center
University of Washington Medical Center
Seattle Cancer Care Alliance
Lillie D. Shockney, RN
John Hopkins Breast Center
Association of Oncology Nurse Navigators
Jonas de Souza, MD
Humana
Patient Access Network Foundation
Yousuf Zafar, MD
Duke Cancer Center